Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 803 of 1,261

  1. US 8785499

    Targeting NAD biosynthesis in bacterial pathogens

    The Board of Regents of the University of Texas System · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  2. US 8785514

    Dual-cure dental resins and adhesives with increased cure and color stability and low color

    The Board of Regents of the University of Texas System · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  3. US 8785491

    Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  4. US 8784817

    Method for killing IL-1 alpha expressing cells

    XBIOTECH INC. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  5. US 8784802

    Ischemic tissue cell therapy

    Cryopraxis Criobiologia Ltda. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  6. US 8784849

    Hydroxyapatite-targeting poly(ethylene glycol) and related polymers

    Nektar Therapeutics · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  7. US 8784780

    High oil-content emollient aerosol foam compositions

    Precision Dermatology, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  8. US 8785633

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  9. US 8785492

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  10. US 8785487

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  11. US 8785476

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  12. US 8785450

    Therapeutic compounds and compositions

    Agios Pharmaceuticals, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  13. US 8785640

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  14. AU 2012362562

    Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetyl aminoisoindoline-1,3-dione

    CELGENE CORP [CH] · Granted Jul 17, 2014 · Expires Jul 12, 2034

    granted

  15. US 8778907

    Lactulose for bowel evacuation

    Cumberland Pharmaceuticals Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  16. US 8778889

    Antimicrobial decapeptide oral hygiene treatment

    The United States of America as represented by the Secretary of the Army · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  17. US 8778897

    Method of treatment using α-1-adrenergic agonist compounds

    The Regents of the University of California · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  18. US 8778898

    Oligomer conjugates of heteropentacyclic nucleosides

    Nektar Therapeutics · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  19. US 8778347

    Fluorescent neutralization and adherence inhibition assays

    SANOFI PASTEUR VAXDESIGN CORPORATION · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  20. US 8778354

    Compositions and methods for modulating RSV infection and immunity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  21. US 8778633

    Transcription factor modulator

    Molecular Discover Systems · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  22. US 8779128

    Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

    Sarepta Therapeutics, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  23. US 8778997

    Antiviral treatments

    BioCryst Pharmaceuticals, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  24. US 8778913

    Antimicrobial compositions for treating microbial infections

    The Regents of the University of California · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.